Angela Lamarca/X
Dec 8, 2024, 05:13
Angela Lamarca: Update form CHECKMATE-9DW trial in HCC – Asian population with Ipilimumab and nivolumab
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:
“Update form CHECKMATE-9DW trial in HCC – Asian population with Ipilimumab and nivolumab, ESMO.
94% with lenva in control arm.
Similar benefit despite higher VHB (62%) – aetiology of no much relevance (again).
Less use of high dose steroids (vs general population).”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 8, 2024, 04:49
Dec 8, 2024, 04:47
Dec 8, 2024, 04:24
Dec 8, 2024, 04:08